Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

The discontinuation of U.S. funding for HIV prevention under Trump's administration has severely impacted vulnerable ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on treatment since the end of February. But can it really be, especially since ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

South Africa’s leadership of the G20 this year is critical for global public health, as it works to tackle the inequalities ...

In its latest budget request, the administration aims to slash 38 percent, or $2.9 billion, from the U.S. President’s ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...